Atlas Trials

Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma

Clinical trial NCT00678327 · COMPLETED

Trial details

NCT number
NCT00678327
Sponsor
University College, London
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lymphoma
Start date
2008-08-29
Primary completion
2016-01-31
Enrollment
1202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.